British scientists have begun testing the first drug of its kind to treat multiple types of cancer, according to British News site "Sky News." The source clarified that experts have started testing the mRNA drug on British patients, noting that the "game-changing" drug is capable of stopping skin, bladder, lung, and kidney cancer.
It was added that the drug is specifically designed for each person and aims to instruct the body to recognize cancer cells and prevent the disease from returning. The trials, now in their second phase, found that the dosage significantly reduces the risk of cancer recurrence in skin cancer patients.
Final trials have now been launched, led by the University College London Hospitals NHS Foundation Trust. The coordinating doctor for the trials, Heather Shaw, mentioned, "It's one of the most exciting things we have seen in a long time," emphasizing that "patients are extremely enthusiastic."
"Sky News" reported that the drug, injected into the bloodstream, can stimulate the immune system to fight a specific type of cancer in the patient. To create a treatment specifically tailored to each individual, a tumor sample is removed, and its DNA is sequenced, with artificial intelligence also playing a role. The goal is to treat cancer and eliminate any cells that may not be visible during screenings.
